Evidence map›Paper›PMID 35812523›Full record

ArticleFrontiers in public health2022

XGBoost-Based Feature Learning Method for Mining COVID-19 Novel Diagnostic Markers.

Xianbin Song, Jiangang Zhu, Xiaoli Tan, Wenlong Yu, Qianqian Wang, Dongfeng Shen, Wenyu Chen

Abstract read
In one paragraph

Article in Frontiers in public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xianbin SongDepartment of Critical Care Medicine, Affiliated Hospital of Jiaxing University, Jiaxing, China.
Jiangang ZhuDepartment of Critical Care Medicine, Affiliated Hospital of Jiaxing University, Jiaxing, China.
Xiaoli TanDepartment of Respiration, Affiliated Hospital of Jiaxing University, Jiaxing, China.
Wenlong YuDepartment of Critical Care Medicine, Affiliated Hospital of Jiaxing University, Jiaxing, China.
Qianqian WangDepartment of Critical Care Medicine, Affiliated Hospital of Jiaxing University, Jiaxing, China.
Dongfeng ShenDepartment of Critical Care Medicine, Affiliated Hospital of Jiaxing University, Jiaxing, China.
Wenyu ChenDepartment of Respiration, Affiliated Hospital of Jiaxing University, Jiaxing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In December 2019, an outbreak of novel coronavirus pneumonia spread over Wuhan, Hubei Province, China, which then developed into a significant global health public event, giving rise to substantial economic losses. We downloaded throat swab expression profiling data of COVID-19 positive and negative patients from the Gene Expression Omnibus (GEO) database to mine novel diagnostic biomarkers. XGBoost was used to construct the model and select feature genes. Subsequently, we constructed COVID-19 classifiers such as MARS, KNN, SVM, MIL, and RF using machine learning methods. We selected the KNN classifier with the optimal MCC value from these classifiers using the IFS method to identify 24 feature genes. Finally, we used principal component analysis to classify the samples and found that the 24 feature genes could effectively be used to classify COVID-19-positive and negative patients. Additionally, we analyzed the possible biological functions and signaling pathways in which the 24 feature genes were involved by GO and KEGG enrichment analyses. The results demonstrated that these feature genes were primarily enriched in biological functions such as viral transcription and viral gene expression and pathways such as Coronavirus disease-COVID-19. In summary, the 24 feature genes we identified were highly effective in classifying COVID-19 positive and negative patients, which could serve as novel markers for COVID-19.

Indexed as

COVID-19PneumoniaBiomarkersHumansMachine LearningSARS-CoV-2BiomarkersCOVID-19diagnostic markersmachine learningprincipal component analysisXGBoost

Identifiers

PMID35812523
PMCPMC9256927

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.